31.02
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AMPH Giù?
Forum
Previsione
Amphastar Pharmaceuticals Inc Borsa (AMPH) Ultime notizie
How the (AMPH) price action is used to our Advantage - Stock Traders Daily
State of Alaska Department of Revenue Sells 342 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Polaris Capital Management LLC Buys Shares of 24,500 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Unpacking Q3 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) In The Context Of Other Generic Pharmaceuticals Stocks - The Globe and Mail
Amphastar stock hits 52-week low at $31.54 amid market challenges - Investing.com Canada
Amphastar Pharmaceuticals (NASDAQ:AMPH) Reaches New 12-Month LowWhat's Next? - MarketBeat
Amphastar stock hits 52-week low at $34.08 amid market challenges - Investing.com Nigeria
Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - Simply Wall St
Amphastar Pharmaceuticals (NASDAQ:AMPH) Shares Gap DownShould You Sell? - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Rating Lowered by Piper Sandler - MarketBeat
Boston Trust Walden Corp Purchases 439,281 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Reaches New 52-Week LowHere's Why - MarketBeat
Piper Sandler Downgrades Amphastar Pharmaceuticals (NASDAQ:AMPH) to Neutral - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Sees Large Growth in Short Interest - MarketBeat
Piper Sandler Downgrades Amphastar Pharmaceuticals (AMPH) - MSN
Piper Sandler cuts Amphastar stock rating, slashes price target By Investing.com - Investing.com Canada
Market Resilience: Amphastar Pharmaceuticals Inc (AMPH) Finishes Weak at 33.39, Down -4.24 - The Dwinnex
This Ollie's Bargain Outlet Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Benzinga
Piper Sandler Downgrades Amphastar Pharmaceuticals to Neutral From Overweight, Adjusts Price Target to $36 From $66 - Marketscreener.com
Piper Sandler cuts Amphastar stock rating, slashes price target - MSN
Long Term Trading Analysis for (AMPH) - Stock Traders Daily
Amphastar Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference - ACCESS Newswire
BofA Adjusts Price Target on Amphastar Pharmaceuticals to $44 From $46 -February 03, 2025 at 10:16 am EST - Marketscreener.com
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Purchased by Pacer Advisors Inc. - MarketBeat
Amphastar Pharmaceuticals is Now Oversold (AMPH) - Nasdaq
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2021 - ACCESS Newswire
Amphastar Pharmaceuticals Receives FDA Approval for Naloxone Hydrochloride Nasal Spray 4mg - ACCESS Newswire
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2023 - ACCESS Newswire
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024 - ACCESS Newswire
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2024 - ACCESS Newswire
Amphastar Pharmaceuticals Announces Pricing of Offering of $300.0 Million of Convertible Senior Notes - ACCESS Newswire
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024 - ACCESS Newswire
Amphastar Receives FDA Approval for Vasopressin - ACCESS Newswire
Amphastar Pharmaceuticals to Present at the Barclays 26th Annual Global Healthcare Conference - ACCESS Newswire
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 28, 2023 - ACCESS Newswire
Amphastar Announces Additional $50 Million Increase to its Share Buyback Program - ACCESS Newswire
(AMPH) Technical Data - Stock Traders Daily
Amphastar Receives FDA Approval for Ganirelix Acetate Injection - ACCESS Newswire
Possible Bearish Signals With Amphastar Pharmaceuticals Insiders Disposing Stock - Simply Wall St
Assenagon Asset Management S.A. Sells 5,956 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Short Interest Up 10.3% in December - MarketBeat
Amphastar stock hits 52-week low at $34.6 amid market challenges - MSN
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):